![These highlights do not include all the information needed to use GILENYA® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010 These highlights do not include all the information needed to use GILENYA® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=gilenya-04.jpg&id=689872)
These highlights do not include all the information needed to use GILENYA® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010
![Novartis' Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis Novartis' Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis](https://multiplesclerosisnewstoday.com/wp-content/uploads/2015/06/shutterstock_188507711-II-1200x900-cropped.jpg)
Novartis' Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis
![These highlights do not include all the information needed to use GILENYA® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010 These highlights do not include all the information needed to use GILENYA® safely and effectively. See full prescribing information for GILENYA. GILENYA (fingolimod) capsules, for oral use Initial U.S. Approval: 2010](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=gilenya-03.jpg&id=689872)